Applied Radiology
LOGIN TO YOUR MYAR CE ACCOUNT
Forgot Your Password? Register Submit
Applied Radiation Expert Forum
Use of Contrast-Enhanced MRI in 'At Risk' Patient Populations
Use of Contrast-Enhanced MRI in 'At Risk' Patient Populations
Credits: 1.0 Category A, ARRT credit  |  1.0 AHRA CRA credit
CE Effective Date: July 28, 2022  |  CE Expiration Date: August 31, 2024
Format: Self Instructional - Audio Visual, Video with Slides

Supported by GE Healthcare

Gadolinium-based contrast agents (GBCAs) differ in structure and ionicity which, in turn affects their stability and safety profiles. The more stable agents are associated with a lower risk of nephrogenic systemic fibrosis (NSF) and less Gd deposition in brain, bone, and other tissues. Several patient populations are considered vulnerable to Gd exposure, including children, the elderly, the renally impaired, and those that require repeat MRI exams.

In these cases, GBCA utilization should be limited to studies where the results contribute significantly to the diagnosis and/or patient management.

In the following webinar and corresponding monograph, Lawrence N. Tanenbaum, MD, FACR and Donna Roberts, MD share case examples including MRI applications and considerations for understanding at risk adult and pediatric patient populations when performing Neuro MRI.

To participate select the appropriate profession and format below.
Contrast-Enhanced MRI
Contrast-Enhanced MRI: Optimizing Imaging of the Brain and Spine
Credits: 1.0 Category A, ARRT credit  |  1.0 AHRA CRA credit
CE Effective Date: November 24, 2021  |  CE Expiration Date: November 30, 2023
Format: Self Instructional - Audio Visual, Video with Slides

Supported by GE Healthcare

In this Expert Forum, Lawrence Tanenbaum, MD, FACR and Suzie Bash, MD review considerations for optimizing contrast-enhanced MRI in neuroimaging, extending from patient tolerance to standardizing procedures. Following the presentation questions from the audience were addressed in a moderated Q&A session.

To participate select the appropriate profession below.
MR Contrast Agents
MR Contrast Agents: Safety Considerations and Clinical Practices
Credits: 1.0 Category A, ARRT credit  |  1.0 AHRA CRA credit
CE Effective Date: November 22, 2021  |  CE Expiration Date: November 30, 2023
Format: Self Instructional - Audio Visual, Video with Slides

Supported by GE Healthcare

In this Expert Forum, Dr. Lawrence Tanenbaum, MD, FACR, will review the classification of Gadolinium MR contrast agents according to their molecular structure, ionicity, and stability. The impact of these properties and supporting clinical data for safety considerations in choosing an agent will be discussed with the goal of providing insight that can be applied in everyday clinical practice. Following the presentation questions from the audience were addressed in a moderated Q&A session.

To participate select the appropriate profession below.
MR Contrast Agents
MR Contrast Agents: A Review of the Current Agents & Their Safety Profile
Credits: 1 Category A, ARRT credit  |  1 AHRA CRA credit
CME Effective Date: December 1, 2020  |  CME Expiration Date: November 30, 2022
Format: Self Instructional - Audio Visual, Video with Slides

This program is supported through an unrestricted educational grant from GE Healthcare.

Today, with such a wide selection of gadolinium-based contrast agents available to choose from; imaging professionals must be aware of the chemical make-up when selecting an MR agent for a particular exam.

Join us for this CME/CE accredited webinar with Lawrence N. Tanenbaum, MD, FACR, who provides a review of the currently available FDA-approved MR contrast agents and their safety profiles. Following Dr. Tanenbaum's presentation questions from the audience were addressed in a moderated Q&A session.

To participate select the appropriate profession below.